Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 263 articles: HTML format

Single Articles

January 2023
1. DAMMU H, Ren T, Duong TQ
   Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
   PLoS One. 2023;18:e0280148.
   PubMed     Abstract available
   
   
   
2. YUAN Y, Liu X, Cai Y, Li W, et al
   Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.
   PLoS One. 2023;18:e0279775.
   PubMed     Abstract available
   
   
   
3. ISLAM N, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al
   Coping strategy among the women with metastatic breast cancer attending a palliative care unit of a tertiary care hospital of Bangladesh.
   PLoS One. 2023;18:e0278620.
   PubMed     Abstract available
   
   
   
4. 
   Retraction: Synthesis, Characterization and In Vitro Study of Biocompatible Cinnamaldehyde Functionalized Magnetite Nanoparticles (CPGF Nps) For Hyperthermia and Drug Delivery Applications in Breast Cancer.
   PLoS One. 2023;18:e0280492.
   PubMed    
   
   
   
5. HU G, Ding Q, Zhong K, Wang S, et al
   Low pretreatment prognostic nutritional index predicts poor survival in breast cancer patients: A meta-analysis.
   PLoS One. 2023;18:e0280669.
   PubMed     Abstract available
   
   
   
6. ZHENG H, Ge C, Lin H, Zhou S, et al
   The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.
   PLoS One. 2023;18:e0280474.
   PubMed     Abstract available
   
   
   
7. FLOOD E, Krasnow A, Orbegoso C, Karantzoulis S, et al
   Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
   PLoS One. 2023;18:e0280259.
   PubMed     Abstract available
   
   
   
8. SYED A, Adam R, Ren T, Lu J, et al
   Machine learning with textural analysis of longitudinal multiparametric MRI and molecular subtypes accurately predicts pathologic complete response in patients with invasive breast cancer.
   PLoS One. 2023;18:e0280320.
   PubMed     Abstract available
   
   
   
9. JANG SJ, Moon C
   Aquaporin 5 (AQP5) expression in breast cancer and its clinicopathological characteristics.
   PLoS One. 2023;18:e0270752.
   PubMed     Abstract available
   
   
   
10. NORMANN LS, Haugen MH, Hongisto V, Aure MR, et al
    High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.
    PLoS One. 2023;18:e0280507.
    PubMed     Abstract available
    
    
    
11. WU R, Luo J, Wan H, Zhang H, et al
    Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database.
    PLoS One. 2023;18:e0280340.
    PubMed     Abstract available
    
    
    
12. MISGANAW M, Zeleke H, Mulugeta H, Assefa B, et al
    Mortality rate and predictors among patients with breast cancer at a referral hospital in northwest Ethiopia: A retrospective follow-up study.
    PLoS One. 2023;18:e0279656.
    PubMed     Abstract available
    
    
    
13. HE Y, Chen S, Gao X, Fu L, et al
    Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.
    PLoS One. 2023;18:e0280456.
    PubMed     Abstract available
    
    
    
14. WESTHOFF CC, Muller SK, Jank P, Kalder M, et al
    Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma.
    PLoS One. 2023;18:e0280936.
    PubMed     Abstract available
    
    
    
15. YAN B, Shi R, Lu YY, Fang DD, et al
    Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer.
    PLoS One. 2023;18:e0279752.
    PubMed     Abstract available
    
    
    
16. LOPEZ-PANISELLO MB, Perez-Lacasta MJ, Rue M, Carles-Lavila M, et al
    Factors influencing intention to participate in breast cancer screening. An exploratory structural model.
    PLoS One. 2023;18:e0281454.
    PubMed     Abstract available
    
    
    
17. LIU R, Ospanova S, Perry RJ
    The impact of variance in carnitine palmitoyltransferase-1 expression on breast cancer prognosis is stratified by clinical and anthropometric factors.
    PLoS One. 2023;18:e0281252.
    PubMed     Abstract available
    
    
    
18. DHAKAL R, Adhikari C, Karki P, Neupane N, et al
    Attitude sustains longer than subjective norm and perceived behavioral control: Results of breast cancer screening educational intervention.
    PLoS One. 2023;18:e0281184.
    PubMed     Abstract available
    
    
    
19. RODRIGUEZ IJ, Bernal-Estevez DA, Llano-Leon M, Bonilla CE, et al
    Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients.
    PLoS One. 2023;18:e0280851.
    PubMed     Abstract available
    
    
    
20. JAYASEKERA LP, Ranasinghe R, Senathilake KS, Kotelawala JT, et al
    Mitochondrial genome in sporadic breast cancer: A case control study and a proteomic analysis in a Sinhalese cohort from Sri Lanka.
    PLoS One. 2023;18:e0281620.
    PubMed     Abstract available
    
    
    
21. BOUCHMAA N, Ben Mrid R, Bouargalne Y, Ajouaoi S, et al
    In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer.
    PLoS One. 2023;18:e0272781.
    PubMed     Abstract available
    
    
    
22. DELGADO AB, Tylden ES, Lukic M, Moi L, et al
    Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
    PLoS One. 2023;18:e0281218.
    PubMed     Abstract available
    
    
    
23. MAPANGA W, Norris SA, Craig A, Ayeni OA, et al
    Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.
    PLoS One. 2023;18:e0281916.
    PubMed     Abstract available
    
    
    
24. ALMEIDA SS, Oliveira MA, Medeiros R, Guerra MP, et al
    Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol.
    PLoS One. 2023;18:e0279344.
    PubMed     Abstract available
    
    
    
25. GONG W, Fang P, Leng M, Shi Y, et al
    Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 / Taxol cells.
    PLoS One. 2023;18:e0282244.
    PubMed     Abstract available
    
    
    
26. LESER C, Dorffner G, Marhold M, Rutter A, et al
    Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study.
    PLoS One. 2023;18:e0278454.
    PubMed     Abstract available
    
    
    
27. PADAMSEE TJ, Muraveva A, Meadows RJ, Hils M, et al
    Racial differences in prevention decision making among U.S. women at high risk of breast cancer: A qualitative study.
    PLoS One. 2023;18:e0278742.
    PubMed     Abstract available
    
    
    
28. FROST CJ, Ramirez-Mata A, Khattri RB, Merritt ME, et al
    Effects of beta-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells.
    PLoS One. 2023;18:e0281396.
    PubMed     Abstract available
    
    
    
29. LI Z, Wang Q, Xu J, Song Q, et al
    Comparative efficacy and acceptability of interventions for insomnia in breast cancer patients: A protocol for systematic review and network meta-analysis.
    PLoS One. 2023;18:e0282614.
    PubMed     Abstract available
    
    
    
30. SHITA A, Yalew AW, Seife E, Afework T, et al
    Survival and predictors of breast cancer mortality in South Ethiopia: A retrospective cohort study.
    PLoS One. 2023;18:e0282746.
    PubMed     Abstract available
    
    
    
31. SCHOUSTRA SM, De Santi B, Op 't Root TJPM, Klazen CAH, et al
    Imaging breast malignancies with the Twente Photoacoustic Mammoscope 2.
    PLoS One. 2023;18:e0281434.
    PubMed     Abstract available
    
    
    
32. LIU P, Roberts S, Shoemaker JT, Vukasinovic J, et al
    Validation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissues.
    PLoS One. 2023;18:e0283044.
    PubMed     Abstract available
    
    
    
33. ALMESHARI M, Alzamil Y, Alyahyawi A, Abanomy A, et al
    Awareness level, knowledge and attitude towards breast cancer among staff and students of Hail University, Saudi Arabia.
    PLoS One. 2023;18:e0282916.
    PubMed     Abstract available
    
    
    
34. 
    Retraction: Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation.
    PLoS One. 2023;18:e0283354.
    PubMed    
    
    
    
35. ROCHE S, Gaule P, Winrow D, Mukherjee N, et al
    Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
    PLoS One. 2023;18:e0282512.
    PubMed     Abstract available
    
    
    
36. CHEN R, Li P, Fu Y, Wu Z, et al
    Chaperone-mediated autophagy promotes breast cancer angiogenesis via regulation of aerobic glycolysis.
    PLoS One. 2023;18:e0281577.
    PubMed     Abstract available
    
    
    
37. PARKER G, Hunter S, Ghazi S, Hayeems RZ, et al
    Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review.
    PLoS One. 2023;18:e0280582.
    PubMed     Abstract available
    
    
    
38. LEE JJ, Choi HR, Choi EP, Ho MH, et al
    Psychometric evaluation of Korean version of COVID-19 fear scale (K-FS-8): A population based cross-sectional study.
    PLoS One. 2023;18:e0282589.
    PubMed     Abstract available
    
    
    
39. 
    Retraction: Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-kappaB Activation.
    PLoS One. 2023;18:e0283750.
    PubMed    
    
    
    
40. LEHTONEN AJ, Arasalo O, Srbova L, Heilala M, et al
    Magnetic microrheometry of tumor-relevant stiffness levels and probabilistic quantification of viscoelasticity differences inside 3D cell culture matrices.
    PLoS One. 2023;18:e0282511.
    PubMed     Abstract available
    
    
    
41. GORDON JAR, Evans MF, Ghule PN, Lee K, et al
    Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.
    PLoS One. 2023;18:e0282473.
    PubMed     Abstract available
    
    
    
42. CHEN J
    Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.
    PLoS One. 2023;18:e0283004.
    PubMed     Abstract available
    
    
    January 2022
43. MASCIA F, Mazo I, Alterovitz WL, Karagiannis K, et al
    In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.
    PLoS One. 2022;17:e0262134.
    PubMed     Abstract available
    
    
    
44. MOHAMED EA, Rashed EA, Gaber T, Karam O, et al
    Deep learning model for fully automated breast cancer detection system from thermograms.
    PLoS One. 2022;17:e0262349.
    PubMed     Abstract available
    
    
    
45. HUTAJULU SH, Prabandari YS, Bintoro BS, Wiranata JA, et al
    Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.
    PLoS One. 2022;17:e0262468.
    PubMed     Abstract available
    
    
    
46. ZAHRAN AM, Rayan A, Zahran ZAM, Mohamed WMY, et al
    Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
    PLoS One. 2022;17:e0262650.
    PubMed     Abstract available
    
    
    
47. HOZHABRI H, Ghasemi Dehkohneh RS, Razavi SM, Razavi SM, et al
    Comparative analysis of protein-protein interaction networks in metastatic breast cancer.
    PLoS One. 2022;17:e0260584.
    PubMed     Abstract available
    
    
    
48. SILVA DAS
    Hospitalization and ambulatory costs related to breast cancer due to physical inactivity in the Brazilian state capitals.
    PLoS One. 2022;17:e0261019.
    PubMed     Abstract available
    
    
    
49. CAO X, Li Y, Wang Y, Yu T, et al
    Curcumin suppresses tumorigenesis by ferroptosis in breast cancer.
    PLoS One. 2022;17:e0261370.
    PubMed     Abstract available
    
    
    
50. MURAYAMA MA, Takada E, Takai K, Arimitsu N, et al
    Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells.
    PLoS One. 2022;17:e0260838.
    PubMed     Abstract available
    
    
    
51. TOMAS RC, Sayat AJ, Atienza AN, Danganan JL, et al
    Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks.
    PLoS One. 2022;17:e0262489.
    PubMed     Abstract available
    
    
    
52. SHI D, Li H, Zhang Z, He Y, et al
    Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.
    PLoS One. 2022;17:e0262389.
    PubMed     Abstract available
    
    
    
53. HUSSAIN I, Majeed A, Masood I, Ashraf W, et al
    A national survey to assess breast cancer awareness among the female university students of Pakistan.
    PLoS One. 2022;17:e0262030.
    PubMed     Abstract available
    
    
    
54. RAJAGOPAL T, Seshachalam A, Rathnam KK, Talluri S, et al
    Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women.
    PLoS One. 2022;17:e0259761.
    PubMed     Abstract available
    
    
    
55. LAZA-VASQUEZ C, Codern-Bove N, Cardona-Cardona A, Hernandez-Leal MJ, et al
    Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.
    PLoS One. 2022;17:e0263788.
    PubMed     Abstract available
    
    
    
56. TSUI TCO, Trudeau M, Mitsakakis N, Torres S, et al
    Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
    PLoS One. 2022;17:e0262635.
    PubMed     Abstract available
    
    
    
57. MARQUES AD, Moura AR, Hora EC, Brito EAC, et al
    Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.
    PLoS One. 2022;17:e0263222.
    PubMed     Abstract available
    
    
    
58. HESARI E, Ahmadinezhad M, Arshadi M, Azizi H, et al
    The association between migraine and breast cancer risk: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263628.
    PubMed     Abstract available
    
    
    
59. TSCHODU D, Ulm B, Bendrat K, Lippoldt J, et al
    Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature.
    PLoS One. 2022;17:e0261035.
    PubMed     Abstract available
    
    
    
60. AKOKO LO, Rutashobya AK, Lutainulwa EW, Mwanga AH, et al
    The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among black Tanzanian women: A case control study.
    PLoS One. 2022;17:e0263374.
    PubMed     Abstract available
    
    
    
61. KILBAS PO, Can ND, Kizilboga T, Ezberci F, et al
    CRISPR/Cas9-mediated Bag-1 knockout increased mesenchymal characteristics of MCF-7 cells via Akt hyperactivation-mediated actin cytoskeleton remodeling.
    PLoS One. 2022;17:e0261062.
    PubMed     Abstract available
    
    
    
62. LV Z, Zhang W, Zhang Y, Zhong G, et al
    Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study.
    PLoS One. 2022;17:e0263104.
    PubMed     Abstract available
    
    
    
63. PADMANABHAN H, Hassan NT, Wong SW, Lee YQ, et al
    Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
    PLoS One. 2022;17:e0263675.
    PubMed     Abstract available
    
    
    
64. CONTE F, Sibilio P, Grimaldi AM, Salvatore M, et al
    In silico recognition of a prognostic signature in basal-like breast cancer patients.
    PLoS One. 2022;17:e0264024.
    PubMed     Abstract available
    
    
    
65. MARKELLOS C, Ourailidou ME, Gavriatopoulou M, Halvatsiotis P, et al
    Olive oil intake and cancer risk: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0261649.
    PubMed     Abstract available
    
    
    
66. NELSON DR, Brown J, Morikawa A, Method M, et al
    Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.
    PLoS One. 2022;17:e0264637.
    PubMed     Abstract available
    
    
    
67. TSAI CJ, Huang HY, Chen FM, Yang YH, et al
    Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ.
    PLoS One. 2022;17:e0262934.
    PubMed     Abstract available
    
    
    
68. MAHMOOD T, Li J, Pei Y, Akhtar F, et al
    Breast lesions classifications of mammographic images using a deep convolutional neural network-based approach.
    PLoS One. 2022;17:e0263126.
    PubMed     Abstract available
    
    
    
69. KWON D, Ko BK, Jung SP, Kim HK, et al
    Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
    PLoS One. 2022;17:e0262709.
    PubMed     Abstract available
    
    
    
70. TROUGHTON LD, O'Loughlin DA, Zech T, Hamill KJ, et al
    Laminin N-terminus alpha31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
    PLoS One. 2022;17:e0264430.
    PubMed     Abstract available
    
    
    
71. KOLODZIEJ M, Kaznowska E, Paszek S, Cebulski J, et al
    Characterisation of breast cancer molecular signature and treatment assessment with vibrational spectroscopy and chemometric approach.
    PLoS One. 2022;17:e0264347.
    PubMed     Abstract available
    
    
    
72. KIM H, Lee SB, Kim J, Chung IY, et al
    Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
    PLoS One. 2022;17:e0265533.
    PubMed     Abstract available
    
    
    
73. XU X, Soulos PR, Herrin J, Wang SY, et al
    Perioperative magnetic resonance imaging in breast cancer care: Distinct adoption trajectories among physician patient-sharing networks.
    PLoS One. 2022;17:e0265188.
    PubMed     Abstract available
    
    
    
74. SHI SC, Zhang Y, Wang T
    High RRM2 expression has poor prognosis in specific types of breast cancer.
    PLoS One. 2022;17:e0265195.
    PubMed     Abstract available
    
    
    
75. ZHU J, Oh JH, Deasy JO, Tannenbaum AR, et al
    vWCluster: Vector-valued optimal transport for network based clustering using multi-omics data in breast cancer.
    PLoS One. 2022;17:e0265150.
    PubMed     Abstract available
    
    
    
76. BOUJEMAA M, Mighri N, Chouchane L, Boubaker MS, et al
    Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
    PLoS One. 2022;17:e0265638.
    PubMed     Abstract available
    
    
    
77. LIU J, Ho PJ, Tan THL, Yeoh YS, et al
    BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.
    PLoS One. 2022;17:e0265965.
    PubMed     Abstract available
    
    
    
78. BOMMI-REDDY A, Park-Chouinard S, Mayhew DN, Terzo E, et al
    CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.
    PLoS One. 2022;17:e0262378.
    PubMed     Abstract available
    
    
    
79. CHUAYCHAI A, Sriplung H
    A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.
    PLoS One. 2022;17:e0265417.
    PubMed     Abstract available
    
    
    
80. ULLAH F, Khurshid N, Fatimi Q, Loidl P, et al
    Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer.
    PLoS One. 2022;17:e0266196.
    PubMed     Abstract available
    
    
    
81. FLORES-GARCIA LC, Ventura-Gallegos JL, Romero-Cordoba SL, Hernandez-Juarez AJ, et al
    Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model.
    PLoS One. 2022;17:e0266073.
    PubMed     Abstract available
    
    
    
82. PETROCCHI S, Ongaro G, Calvello M, Feroce I, et al
    A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
    PLoS One. 2022;17:e0266327.
    PubMed     Abstract available
    
    
    
83. FILIPOWICZ N, Drezek K, Horbacz M, Wojdak A, et al
    Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
    PLoS One. 2022;17:e0266111.
    PubMed     Abstract available
    
    
    
84. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed     Abstract available
    
    
    
85. CHEN PC, Lee YC, Su YC, Lee CH, et al
    Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan.
    PLoS One. 2022;17:e0266960.
    PubMed     Abstract available
    
    
    
86. PEREZ CS, Mestriner C, Ribeiro LTN, Grillo FW, et al
    Relationship between lymphedema after breast cancer treatment and biophysical characteristics of the affected tissue.
    PLoS One. 2022;17:e0264160.
    PubMed     Abstract available
    
    
    
87. SQUARA PA, Luu VP, Perol D, Coudert B, et al
    Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.
    PLoS One. 2022;17:e0267242.
    PubMed     Abstract available
    
    
    
88. HU H, Qiao S, Hao Y, Bai Y, et al
    Breast cancer histopathological images recognition based on two-stage nuclei segmentation strategy.
    PLoS One. 2022;17:e0266973.
    PubMed     Abstract available
    
    
    
89. NUNEZ-RUIZ A, Sanchez-Brena F, Lopez-Pacheco C, Acevedo-Dominguez NA, et al
    Obesity modulates the immune macroenvironment associated with breast cancer development.
    PLoS One. 2022;17:e0266827.
    PubMed     Abstract available
    
    
    
90. AI H
    GSEA-SDBE: A gene selection method for breast cancer classification based on GSEA and analyzing differences in performance metrics.
    PLoS One. 2022;17:e0263171.
    PubMed     Abstract available
    
    
    
91. DAILY A, Ravishankar P, Harms S, Klimberg VS, et al
    Using tears as a non-invasive source for early detection of breast cancer.
    PLoS One. 2022;17:e0267676.
    PubMed     Abstract available
    
    
    
92. TZELVES L, Manolitsis I, Varkarakis I, Ivanovic M, et al
    Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
    PLoS One. 2022;17:e0265127.
    PubMed     Abstract available
    
    
    
93. PARK SY, Kim JH, Chang JH, Park JM, et al
    Quantitative evaluation of radiodermatitis following whole-breast radiotherapy with various color space models: A feasibility study.
    PLoS One. 2022;17:e0264925.
    PubMed     Abstract available
    
    
    
94. ARORA I, Sharma M, Li S, Crowley M, et al
    An integrated analysis of the effects of maternal broccoli sprouts exposure on transcriptome and methylome in prevention of offspring mammary cancer.
    PLoS One. 2022;17:e0264858.
    PubMed     Abstract available
    
    
    
95. LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
    Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
    PLoS One. 2022;17:e0264634.
    PubMed     Abstract available
    
    
    
96. HAO Y, Zhang L, Qiao S, Bai Y, et al
    Breast cancer histopathological images classification based on deep semantic features and gray level co-occurrence matrix.
    PLoS One. 2022;17:e0267955.
    PubMed     Abstract available
    
    
    
97. KOYAMA K, Ishikawa H, Abe M, Shiose Y, et al
    Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression.
    PLoS One. 2022;17:e0267027.
    PubMed     Abstract available
    
    
    
98. LI T, Li Y, Yang Y, Li J, et al
    Logistic regression analysis of ultrasound findings in predicting the malignant and benign phyllodes tumor of breast.
    PLoS One. 2022;17:e0265952.
    PubMed     Abstract available
    
    
    
99. UEDA D, Yamamoto A, Onoda N, Takashima T, et al
    Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets.
    PLoS One. 2022;17:e0265751.
    PubMed     Abstract available
    
    
    
100. OSE N, Takeuchi Y, Sakamaki Y, Kadota Y, et al
     Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay.
     PLoS One. 2022;17:e0265603.
     PubMed     Abstract available
     
     
     
101. ANNONI AM, Longhini C
     Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
     PLoS One. 2022;17:e0265387.
     PubMed     Abstract available
     
     
     
102. TAGHIZADEH MS, Niazi A, Moghadam A, Afsharifar A, et al
     Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer.
     PLoS One. 2022;17:e0267961.
     PubMed     Abstract available
     
     
     
103. DAMASCENO KA, Santos-Conceicao AMD, Silva LP, Cardoso TMS, et al
     Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.
     PLoS One. 2022;17:e0267648.
     PubMed     Abstract available
     
     
     
104. SCHLIEMANN D, Hoe WMK, Mohan D, Allotey P, et al
     Challenges and opportunities for breast cancer early detection among rural dwelling women in Segamat District, Malaysia: A qualitative study.
     PLoS One. 2022;17:e0267308.
     PubMed     Abstract available
     
     
     
105. MEDINA HN, Callahan KE, Koru-Sengul T, Maheshwari S, et al
     Elevated breast cancer mortality among highly educated Asian American women.
     PLoS One. 2022;17:e0268617.
     PubMed     Abstract available
     
     
     
106. MA L, Bian M, Gao H, Zhou Z, et al
     A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer.
     PLoS One. 2022;17:e0268060.
     PubMed     Abstract available
     
     
     
107. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
     Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
     PLoS One. 2022;17:e0265881.
     PubMed     Abstract available
     
     
     
108. ALAM MS, Sultana A, Reza MS, Amanullah M, et al
     Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
     PLoS One. 2022;17:e0268967.
     PubMed     Abstract available
     
     
     
109. ZEMNI I, Kacem M, Dhouib W, Bennasrallah C, et al
     Breast cancer incidence and predictions (Monastir, Tunisia: 2002-2030): A registry-based study.
     PLoS One. 2022;17:e0268035.
     PubMed     Abstract available
     
     
     
110. GRANT E, Bucklain FA, Ginn L, Laity P, et al
     Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines.
     PLoS One. 2022;17:e0268300.
     PubMed     Abstract available
     
     
     
111. ONAGA C, Tamori S, Matsuoka I, Ozaki A, et al
     High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.
     PLoS One. 2022;17:e0268799.
     PubMed     Abstract available
     
     
     
112. NGAN TT, Jenkins C, Minh HV, Donnelly M, et al
     Breast cancer screening practices among Vietnamese women and factors associated with clinical breast examination uptake.
     PLoS One. 2022;17:e0269228.
     PubMed     Abstract available
     
     
     
113. TRAN T, Le U, Shi Y
     An effective up-sampling approach for breast cancer prediction with imbalanced data: A machine learning model-based comparative analysis.
     PLoS One. 2022;17:e0269135.
     PubMed     Abstract available
     
     
     
114. NAM KH, Lee JH, Chung YS, Chun YS, et al
     The efficacy of oxidized regenerated cellulose (SurgiGuard(R)) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.
     PLoS One. 2022;17:e0267694.
     PubMed     Abstract available
     
     
     
115. MEURS CJC, Til JAV, Menke-Pluijmers MBE, Vet S, et al
     Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.
     PLoS One. 2022;17:e0269551.
     PubMed     Abstract available
     
     
     
116. TANDA N, Tada H, Washio J, Takahashi N, et al
     Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study.
     PLoS One. 2022;17:e0269335.
     PubMed     Abstract available
     
     
     
117. XIA LY, Xu WY, Zhao Y
     Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
     PLoS One. 2022;17:e0270528.
     PubMed     Abstract available
     
     
     
118. PUSPITANINGTYAS H, Sulistyoningrum DC, Witaningrum R, Widodo I, et al
     Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia.
     PLoS One. 2022;17:e0270507.
     PubMed     Abstract available
     
     
     
119. HARDEMAN AA, Han YJ, Grushko TA, Mueller J, et al
     Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.
     PLoS One. 2022;17:e0268693.
     PubMed     Abstract available
     
     
     
120. SILVA DA COSTA N, Alves da Silva AS, de Melo-Neto JS
     Effects of dance therapy in women with breast cancer: A systematic review protocol.
     PLoS One. 2022;17:e0257948.
     PubMed     Abstract available
     
     
     
121. PIEMONTESE A, Galvain T, Swindells L, Parago V, et al
     Budget impact analysis of HARMONIC FOCUS+ Shears for mastectomy and breast-conserving surgery with axillary lymph node dissection compared with monopolar electrocautery from an Italian hospital perspective.
     PLoS One. 2022;17:e0268708.
     PubMed     Abstract available
     
     
     
122. PARK J, Kim C, Ki Y, Kim W, et al
     Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study.
     PLoS One. 2022;17:e0269893.
     PubMed     Abstract available
     
     
     
123. MENG X, Wang L, He M, Yang Z, et al
     Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
     PLoS One. 2022;17:e0269998.
     PubMed     Abstract available
     
     
     
124. SARKER R, Islam MS, Moonajilin MS, Rahman M, et al
     Knowledge of breast cancer and breast self-examination practices and its barriers among university female students in Bangladesh: Findings from a cross-sectional study.
     PLoS One. 2022;17:e0270417.
     PubMed     Abstract available
     
     
     
125. COX A, Martini A, Ghozlan H, Moroose R, et al
     Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
     PLoS One. 2022;17:e0264651.
     PubMed     Abstract available
     
     
     
126. REME SE, Munk A, Holter MTS, Falk RS, et al
     Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial.
     PLoS One. 2022;17:e0268606.
     PubMed     Abstract available
     
     
     
127. MELLOR P, Kendall S, Smith S, Saxena A, et al
     Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
     PLoS One. 2022;17:e0271090.
     PubMed     Abstract available
     
     
     
128. CZUBAK-PROWIZOR K, Macieja A, Poplawski T, Zbikowska HM, et al
     Responses of human colon and breast adenocarcinoma cell lines (LoVo, MCF7) and non-tumorigenic mammary epithelial cells (MCF-10A) to the acellular fraction of packed red blood cells in the presence and absence of cisplatin.
     PLoS One. 2022;17:e0271193.
     PubMed     Abstract available
     
     
     
129. MESSIER TL, Boyd JR, Gordon JAR, Tye CE, et al
     Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
     PLoS One. 2022;17:e0271725.
     PubMed     Abstract available
     
     
     
130. CONTI B, Bochaton A, Charreire H, Kitzis-Bonsang H, et al
     Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.
     PLoS One. 2022;17:e0271319.
     PubMed     Abstract available
     
     
     
131. DIOSAN L, Andreica A, Voiculescu I
     On the use of multi-objective evolutionary classifiers for breast cancer detection.
     PLoS One. 2022;17:e0269950.
     PubMed     Abstract available
     
     
     
132. YANG Z, Liu J, Wang Q
     Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.
     PLoS One. 2022;17:e0270347.
     PubMed     Abstract available
     
     
     
133. ACEA-NEBRIL B, Garcia-Novoa A, Garcia Jimenez L
     The PreQ-20 TRIAL: A prospective cohort study of the oncologic safety, quality of life and cosmetic outcomes of patients undergoing prepectoral breast reconstruction.
     PLoS One. 2022;17:e0269426.
     PubMed     Abstract available
     
     
     
134. FUNGA ML, Dilebo ZD, Shuramo AG, Bereku T, et al
     Assessing breast cancer awareness on reproductive age women in West Badewacho Woreda, Hadiyya Zone, South Ethiopia; Community based cross- sectional study.
     PLoS One. 2022;17:e0270248.
     PubMed     Abstract available
     
     
     
135. CHEN CC, Ho WL, Lin CH, Chen HH, et al
     Stratified analysis of the association between periodontitis and female breast cancer based on age, comorbidities and level of urbanization: A population-based nested case-control study.
     PLoS One. 2022;17:e0271948.
     PubMed     Abstract available
     
     
     
136. DEY M, Rana SP, Loretoni R, Duranti M, et al
     Automated breast lesion localisation in microwave imaging employing simplified pulse coupled neural network.
     PLoS One. 2022;17:e0271377.
     PubMed     Abstract available
     
     
     
137. WANG J, Chen X, Wang L, Zhang C, et al
     Does aquatic physical therapy affect the rehabilitation of breast cancer in women? A systematic review and meta-analysis of randomized controlled trials.
     PLoS One. 2022;17:e0272337.
     PubMed     Abstract available
     
     
     
138. KHAJAH MA, Khushaish S, Luqmani YA
     Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
     PLoS One. 2022;17:e0272449.
     PubMed     Abstract available
     
     
     
139. LAZAR IM, Karcini A, Haueis JRS
     Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks.
     PLoS One. 2022;17:e0272384.
     PubMed     Abstract available
     
     
     
140. PE KCS, Saetung R, Yodsurang V, Chaotham C, et al
     Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
     PLoS One. 2022;17:e0273044.
     PubMed     Abstract available
     
     
     
141. YANG Y, Lin Y, Sikapokoo GO, Min SH, et al
     Social relationships and their associations with affective symptoms of women with breast cancer: A scoping review.
     PLoS One. 2022;17:e0272649.
     PubMed     Abstract available
     
     
     
142. AYNALEM M, Adem N, Wendesson F, Misganaw B, et al
     Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center.
     PLoS One. 2022;17:e0271895.
     PubMed     Abstract available
     
     
     
143. NISHI K, Fu W, Kiyama R
     Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.
     PLoS One. 2022;17:e0273164.
     PubMed     Abstract available
     
     
     
144. YANG K, Suzuki A, Ye J, Nosato H, et al
     CTG-Net: Cross-task guided network for breast ultrasound diagnosis.
     PLoS One. 2022;17:e0271106.
     PubMed     Abstract available
     
     
     
145. HLAING MT, Horimoto Y, Denda-Nagai K, Fujihira H, et al
     Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.
     PLoS One. 2022;17:e0273513.
     PubMed     Abstract available
     
     
     
146. SLAGHMUYLDER Y, Pype P, Van Hecke A, Lauwerier E, et al
     Exploring healthcare providers' perceptions regarding the prevention and treatment of chronic pain in breast cancer survivors: A qualitative analysis among different disciplines.
     PLoS One. 2022;17:e0273576.
     PubMed     Abstract available
     
     
     
147. BEAUBRUN-RENARD MM, Veronique-Baudin J, Macni J, Ulric-Gervaise S, et al
     Overall survival of triple negative breast cancer in French Caribbean women.
     PLoS One. 2022;17:e0271966.
     PubMed     Abstract available
     
     
     
148. KEMBOI D, Langat MK, Siwe-Noundou X, Tshiwawa T, et al
     13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico.
     PLoS One. 2022;17:e0271389.
     PubMed     Abstract available
     
     
     
149. 
     Retraction: Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition.
     PLoS One. 2022;17:e0274216.
     PubMed    
     
     
     
150. VICENTE-MUNOZ S, Hunt BG, Lange TE, Wells SI, et al
     NMR-based metabolomic analysis identifies RON-DEK-beta-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
     PLoS One. 2022;17:e0274128.
     PubMed     Abstract available
     
     
     
151. VAN GOGH S, Mukherjee S, Xu J, Wang Z, et al
     Iterative phase contrast CT reconstruction with novel tomographic operator and data-driven prior.
     PLoS One. 2022;17:e0272963.
     PubMed     Abstract available
     
     
     
152. MEYER SB, Lunnay B, Warin M, Foley K, et al
     Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk.
     PLoS One. 2022;17:e0270936.
     PubMed     Abstract available
     
     
     
153. MIGHRI N, Mejri N, Boujemaa M, Berrazega Y, et al
     Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
     PLoS One. 2022;17:e0269732.
     PubMed     Abstract available
     
     
     
154. AL-SANEA MM, Chilingaryan G, Abelyan N, Mamikonyan M, et al
     Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors.
     PLoS One. 2022;17:e0272065.
     PubMed     Abstract available
     
     
     
155. STAAF J, Aine M
     Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data.
     PLoS One. 2022;17:e0265557.
     PubMed     Abstract available
     
     
     
156. LEE C, Kim S, Woo J
     A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
     PLoS One. 2022;17:e0273995.
     PubMed     Abstract available
     
     
     
157. SUN D, Li C, Zhang F
     MicroRNA-206 suppresses growth and metastasis of breast cancer stem cells via blocking EVI-1-mediated CALR expression.
     PLoS One. 2022;17:e0274919.
     PubMed     Abstract available
     
     
     
158. RAHPEIMA R, Lin CA
     Numerical study of magnetic hyperthermia ablation of breast tumor on an anatomically realistic breast phantom.
     PLoS One. 2022;17:e0274801.
     PubMed     Abstract available
     
     
     
159. ASSFA MOSSA K
     Perceptions and knowledge of breast cancer and breast self-examination among young adult women in southwest Ethiopia: Application of the health belief model.
     PLoS One. 2022;17:e0274935.
     PubMed     Abstract available
     
     
     
160. ZHUANG L, Chen H, Zheng X, Wu S, et al
     Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case-control study.
     PLoS One. 2022;17:e0274570.
     PubMed     Abstract available
     
     
     
161. MASSAFRA R, Comes MC, Bove S, Didonna V, et al
     A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
     PLoS One. 2022;17:e0274691.
     PubMed     Abstract available
     
     
     
162. HAMID AB, Frank LE, Bouley RA, Petreaca RC, et al
     Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
     PLoS One. 2022;17:e0273736.
     PubMed     Abstract available
     
     
     
163. CROZIER M, Tubman J, Fifield BA, Ferraiuolo RM, et al
     Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells.
     PLoS One. 2022;17:e0274675.
     PubMed     Abstract available
     
     
     
164. LEE R, Lee HB, Paeng JC, Choi H, et al
     Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer.
     PLoS One. 2022;17:e0275279.
     PubMed     Abstract available
     
     
     
165. RODALLEC A, Vaghi C, Ciccolini J, Fanciullino R, et al
     Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.
     PLoS One. 2022;17:e0274886.
     PubMed     Abstract available
     
     
     
166. ROSERO G, Pattarone G, Penaherera A, Pilz J, et al
     Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1).
     PLoS One. 2022;17:e0274911.
     PubMed     Abstract available
     
     
     
167. IBRAHIM EY, Munshani S, Domenicano I, Rodwin R, et al
     A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.
     PLoS One. 2022;17:e0275648.
     PubMed     Abstract available
     
     
     
168. GOWTHAM HG, Murali M, Singh SB, Shivamallu C, et al
     Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies.
     PLoS One. 2022;17:e0275432.
     PubMed     Abstract available
     
     
     
169. SAKAFU LL, Philipo GS, Malichewe CV, Fundikira LS, et al
     Delayed diagnostic evaluation of symptomatic breast cancer in sub-Saharan Africa: A qualitative study of Tanzanian women.
     PLoS One. 2022;17:e0275639.
     PubMed     Abstract available
     
     
     
170. DEMEKE T, Ayele W, Haile Mariam D, Wienke A, et al
     Health system cost of breast cancer treatment in Addis Ababa, Ethiopia.
     PLoS One. 2022;17:e0275171.
     PubMed     Abstract available
     
     
     
171. HARIKRISHNAN K, Prabhu SS, Balasubramanian N
     A pan-cancer analysis of matrisome proteins reveals CTHRC1 and a related network as major ECM regulators across cancers.
     PLoS One. 2022;17:e0270063.
     PubMed     Abstract available
     
     
     
172. NAM KE, Kim I, Park HY, Lee JI, et al
     The effect of breast cancer surgery on spine alignment: Whole-spine radiograph analysis.
     PLoS One. 2022;17:e0276173.
     PubMed     Abstract available
     
     
     
173. DE BONIFACE J, Altena R, Haddad Ringborg C, Bolam KA, et al
     Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial.
     PLoS One. 2022;17:e0274804.
     PubMed     Abstract available
     
     
     
174. JAGARLAMUDI KK, L S, M Z, J O, et al
     Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
     PLoS One. 2022;17:e0275444.
     PubMed     Abstract available
     
     
     
175. KIBRET YM, Leka YA, Tekle NF, Tigeneh W, et al
     Patterns of cancer in Wolaita Sodo University Hospital: South Ethiopia.
     PLoS One. 2022;17:e0274792.
     PubMed     Abstract available
     
     
     
176. POKORA RM, Buttner M, Schulz A, Schuster AK, et al
     Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS).
     PLoS One. 2022;17:e0275525.
     PubMed     Abstract available
     
     
     
177. A MOHAMED E, Gaber T, Karam O, Rashed EA, et al
     A Novel CNN pooling layer for breast cancer segmentation and classification from thermograms.
     PLoS One. 2022;17:e0276523.
     PubMed     Abstract available
     
     
     
178. CHAN WY, Cheah WK, Ramli Hamid MT, Md Shah MN, et al
     Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer.
     PLoS One. 2022;17:e0274385.
     PubMed     Abstract available
     
     
     
179. LU J, Chen XM, Xie KH
     Effectiveness of nursing interventions on the sexual quality of life of patients with breast cancer: A systematic review and meta-analysis.
     PLoS One. 2022;17:e0277221.
     PubMed     Abstract available
     
     
     
180. MCDONALD JT, Ricks-Santi LJ
     Hereditary variants of unknown significance in African American women with breast cancer.
     PLoS One. 2022;17:e0273835.
     PubMed     Abstract available
     
     
     
181. HAYAT F, Khan NU, Khan AU, Ahmad I, et al
     Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
     PLoS One. 2022;17:e0276813.
     PubMed     Abstract available
     
     
     
182. 
     Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis.
     PLoS One. 2022;17:e0277500.
     PubMed    
     
     
     
183. SYED ALWI SM, Mazlan M, Mohd Taib NA, Che Din N, et al
     A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
     PLoS One. 2022;17:e0277056.
     PubMed     Abstract available
     
     
     
184. CRUZ SJV, Ribeiro AKPL, Pinheiro MDCN, Carneiro VCCB, et al
     Five-year survival rate and prognostic factors in women with breast cancer treated at a reference hospital in the Brazilian Amazon.
     PLoS One. 2022;17:e0277194.
     PubMed     Abstract available
     
     
     
185. XIE N, Shu Q, Wang Z, Huang X, et al
     ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members.
     PLoS One. 2022;17:e0274757.
     PubMed     Abstract available
     
     
     
186. LEE YL, Islam T, Danaee M, Taib NA, et al
     A longitudinal study of physical activity among Malaysian breast cancer survivors.
     PLoS One. 2022;17:e0277982.
     PubMed     Abstract available
     
     
     
187. HUTCHINGS HA, Remesh A
     An evaluation of the readability and visual appearance of online patient resources for fibroadenoma.
     PLoS One. 2022;17:e0277823.
     PubMed     Abstract available
     
     
     
188. JACKSON C, Finikarides L, Freeman ALJ
     The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
     PLoS One. 2022;17:e0275321.
     PubMed     Abstract available
     
     
     
189. LUO J, Chen S, Chen J, Zhou Y, et al
     Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
     PLoS One. 2022;17:e0278270.
     PubMed     Abstract available
     
     
     
190. SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
     Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
     PLoS One. 2022;17:e0278460.
     PubMed     Abstract available
     
     
     
191. TOMSIC S, Zagar T, Mihor A, Mlakar M, et al
     Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening.
     PLoS One. 2022;17:e0278384.
     PubMed     Abstract available
     
     
     
192. KIKAWA Y, Hagiwara Y, Fujisawa T, Araki K, et al
     Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy.
     PLoS One. 2022;17:e0278344.
     PubMed     Abstract available
     
     
     
193. AMEEN F, AlNAdhari S, Al-Homaidan AA
     Marine fungi showing multifunctional activity against human pathogenic microbes and cancer.
     PLoS One. 2022;17:e0276926.
     PubMed     Abstract available
     
     
     
194. TUCKER JD, Doddapaneni R, Lu PJ, Lu QL, et al
     Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer.
     PLoS One. 2022;17:e0278711.
     PubMed     Abstract available
     
     
     
195. LANKREW AYALEW T, Wale BG, Haile KE, Zewudie BT, et al
     Health-related quality of life and associated factors among cancer patients in Ethiopia: Systematic review and meta-analysis.
     PLoS One. 2022;17:e0277839.
     PubMed     Abstract available
     
     
     
196. GUNDOGMUS AG, Sezer Katar K, Orsel S, Ozturk G, et al
     The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer.
     PLoS One. 2022;17:e0277119.
     PubMed     Abstract available
     
     
     
197. ZHANG S, Wang H, Liu B, Yu J, et al
     Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.
     PLoS One. 2022;17:e0279107.
     PubMed     Abstract available
     
     
     
198. CHOUPANI E, Madjd Z, Saraygord-Afshari N, Kiani J, et al
     Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells.
     PLoS One. 2022;17:e0279522.
     PubMed     Abstract available
     
     
     
199. QI SA, Kumar N, Xu JY, Patel J, et al
     Personalized breast cancer onset prediction from lifestyle and health history information.
     PLoS One. 2022;17:e0279174.
     PubMed     Abstract available
     
     
     
200. LING AY, Jreich R, Montez-Rath ME, Meng Z, et al
     Transporting observational study results to a target population of interest using inverse odds of participation weighting.
     PLoS One. 2022;17:e0278842.
     PubMed     Abstract available
     
     
     
201. TAHTAMOUNI L, Alzghoul A, Alderfer S, Sun J, et al
     The role of activated androgen receptor in cofilin phospho-regulation depends on the molecular subtype of TNBC cell line and actin assembly dynamics.
     PLoS One. 2022;17:e0279746.
     PubMed     Abstract available
     
     
     
202. DUTTA D, Sen A, Satagopan J
     Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations.
     PLoS One. 2022;17:e0276886.
     PubMed     Abstract available
     
     
     
203. PREMACHANDRA A, Wang X, Saad M, Moussawy S, et al
     Erector spinae plane block versus thoracic paravertebral block for the prevention of acute postsurgical pain in breast cancer surgery: A prospective observational study compared with a propensity score-matched historical cohort.
     PLoS One. 2022;17:e0279648.
     PubMed     Abstract available
     
     
     January 2021
204. HADJIPANTELI A, Polyviou P, Kyriakopoulos I, Genagritis M, et al
     Comparison of two-view versus single-view digital breast tomosynthesis and 2D-mammography in breast cancer surveillance imaging.
     PLoS One. 2021;16:e0256514.
     PubMed     Abstract available
     
     
     
205. SANI L, Vispa A, Loretoni R, Duranti M, et al
     Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters.
     PLoS One. 2021;16:e0250005.
     PubMed     Abstract available
     
     
     
206. JARM K, Kadivec M, Sval C, Hertl K, et al
     Quality assured implementation of the Slovenian breast cancer screening programme.
     PLoS One. 2021;16:e0258343.
     PubMed     Abstract available
     
     
     
207. SAKSORNCHAI K, Jaruthien T, Nantavithya C, Shotelersuk K, et al
     Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study.
     PLoS One. 2021;16:e0258186.
     PubMed     Abstract available
     
     
     
208. GARCIA MT, Mota BS, Cardoso N, Martimbianco ALC, et al
     Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0248768.
     PubMed     Abstract available
     
     
     
209. XIE Y, Guo B, Zhang R
     Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
     PLoS One. 2021;16:e0248220.
     PubMed     Abstract available
     
     
     
210. MOHAMED RI, Bargal SA, Mekawy AS, El-Shiekh I, et al
     The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
     PLoS One. 2021;16:e0247837.
     PubMed     Abstract available
     
     
     
211. PARK JH, Jung YS, Kim JY, Bae SH, et al
     Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study.
     PLoS One. 2021;16:e0258447.
     PubMed     Abstract available
     
     
     
212. STONE JK, Vukadin L, Ahn EE
     eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
     PLoS One. 2021;16:e0251515.
     PubMed     Abstract available
     
     
     
213. ZOELLER JJ, Press MF, Selfors LM, Dering J, et al
     Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.
     PLoS One. 2021;16:e0251163.
     PubMed     Abstract available
     
     
     
214. BLASI MA, Maceroni M, Caputo CG, Sammarco MG, et al
     Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center.
     PLoS One. 2021;16:e0249210.
     PubMed     Abstract available
     
     
     
215. JAMES JE, Riddle L, Koenig BA, Joseph G, et al
     The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
     PLoS One. 2021;16:e0258571.
     PubMed     Abstract available
     
     
     
216. OPOKU F, Bedu-Addo K, Titiloye NA, Atta Manu E, et al
     Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana.
     PLoS One. 2021;16:e0258543.
     PubMed     Abstract available
     
     
     
217. JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al
     Using a Deliberative Poll on breast cancer screening to assess and improve the decision quality of laypeople.
     PLoS One. 2021;16:e0258869.
     PubMed     Abstract available
     
     
     
218. BROCK EJ, Jackson RM, Boerner JL, Li Q, et al
     Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
     PLoS One. 2021;16:e0252314.
     PubMed     Abstract available
     
     
     
219. AGODIRIN O, Olatoke S, Rahman G, Kolawole O, et al
     Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.
     PLoS One. 2021;16:e0256847.
     PubMed     Abstract available
     
     
     
220. MARES AG, Pacassoni G, Marti JS, Pujals S, et al
     Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology.
     PLoS One. 2021;16:e0251821.
     PubMed     Abstract available
     
     
     
221. AMIRFALLAH A, Knutsdottir H, Arason A, Hilmarsdottir B, et al
     Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
     PLoS One. 2021;16:e0260327.
     PubMed     Abstract available
     
     
     
222. QIU P, Guo Q, Yao Q, Chen J, et al
     Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
     PLoS One. 2021;16:e0254283.
     PubMed     Abstract available
     
     
     
223. HANSEN JA, Naghavi-Behzad M, Gerke O, Baun C, et al
     Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
     PLoS One. 2021;16:e0260066.
     PubMed     Abstract available
     
     
     
224. WU WP, Chen CY, Lee CW, Wu HK, et al
     Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
     PLoS One. 2021;16:e0260093.
     PubMed     Abstract available
     
     
     
225. DARGA EP, Dolce EM, Fang F, Kidwell KM, et al
     PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
     PLoS One. 2021;16:e0260124.
     PubMed     Abstract available
     
     
     
226. MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
     Correction: Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
     PLoS One. 2021;16:e0260106.
     PubMed     Abstract available
     
     
     
227. EZZALFANI M, Porcher R, Savignoni A, Delaloge S, et al
     Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
     PLoS One. 2021;16:e0255017.
     PubMed     Abstract available
     
     
     
228. KAGAYA Y, Arikawa M, Sekiyama T, Mitsuwa H, et al
     The concept of "whole perforator system" in the lateral thoracic region for latissimus dorsi muscle-preserving large flaps: An anatomical study and case series.
     PLoS One. 2021;16:e0256962.
     PubMed     Abstract available
     
     
     
229. PRATOOMCHART C, Klunklin P, Wanwilairat S, Nobnop W, et al
     The advantages of abdominal compression with shallow breathing during left-sided postmastectomy radiotherapy by Helical TomoTherapy.
     PLoS One. 2021;16:e0254934.
     PubMed     Abstract available
     
     
     
230. HE Q, Cheng G, Ju H
     BCDnet: Parallel heterogeneous eight-class classification model of breast pathology.
     PLoS One. 2021;16:e0253764.
     PubMed     Abstract available
     
     
     
231. GUO Y, Duan X, Wang C, Guo H, et al
     Segmentation and recognition of breast ultrasound images based on an expanded U-Net.
     PLoS One. 2021;16:e0253202.
     PubMed     Abstract available
     
     
     
232. GHANBARI S, Salimi A, Rahmani S, Nafissi N, et al
     miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
     PLoS One. 2021;16:e0253009.
     PubMed     Abstract available
     
     
     
233. HARTMANN B, Muller M, Seyler L, Bauerle T, et al
     Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla.
     PLoS One. 2021;16:e0252935.
     PubMed     Abstract available
     
     
     
234. EASLEY TO, Ren Z, Kim B, Karczmar GS, et al
     Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
     PLoS One. 2021;16:e0258621.
     PubMed     Abstract available
     
     
     
235. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
     Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
     PLoS One. 2021;16:e0249809.
     PubMed     Abstract available
     
     
     
236. BRUCKMANN NM, Kirchner J, Morawitz J, Umutlu L, et al
     Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
     PLoS One. 2021;16:e0260804.
     PubMed     Abstract available
     
     
     
237. ADEYEMI OJ, Gill TL, Paul R, Huber LB, et al
     Evaluating the association of self-reported psychological distress and self-rated health on survival times among women with breast cancer in the U.S.
     PLoS One. 2021;16:e0260481.
     PubMed     Abstract available
     
     
     
238. CHOI W, Lee H
     Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
     PLoS One. 2021;16:e0258626.
     PubMed     Abstract available
     
     
     
239. ALACHRAM H, Chereda H, Beissbarth T, Wingender E, et al
     Text mining-based word representations for biomedical data analysis and protein-protein interaction networks in machine learning tasks.
     PLoS One. 2021;16:e0258623.
     PubMed     Abstract available
     
     
     
240. SHAMMOUT ODA, Ashmawy NS, Shakartalla SB, Altaie AM, et al
     Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
     PLoS One. 2021;16:e0258363.
     PubMed     Abstract available
     
     
     
241. KEETILE M, Ndlovu K, Letamo G, Disang M, et al
     Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
     PLoS One. 2021;16:e0255581.
     PubMed     Abstract available
     
     
     
242. LENG X, Huang G, Li S, Yao M, et al
     Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
     PLoS One. 2021;16:e0261138.
     PubMed     Abstract available
     
     
     
243. SON Y, Han K, Lee YS, Yu J, et al
     Privacy-preserving breast cancer recurrence prediction based on homomorphic encryption and secure two party computation.
     PLoS One. 2021;16:e0260681.
     PubMed     Abstract available
     
     
     
244. POLITI MC, Saunders CH, Grabinski VF, Yen RW, et al
     An absence of equipoise: Examining surgeons' decision talk during encounters with women considering breast cancer surgery.
     PLoS One. 2021;16:e0260704.
     PubMed     Abstract available
     
     
     
245. ZHOU Z, Li J, Wang H, Luan Z, et al
     Upper limb rehabilitation system based on virtual reality for breast cancer patients: Development and usability study.
     PLoS One. 2021;16:e0261220.
     PubMed     Abstract available
     
     
     
246. FOMITCHEVA-KHARTCHENKO A, Rapsomaniki MA, Sobottka B, Schraml P, et al
     Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
     PLoS One. 2021;16:e0259332.
     PubMed     Abstract available
     
     
     
247. ZIMMERMANN RC, Sardiu ME, Manton CA, Miah MS, et al
     Perturbation of BRMS1 interactome reveals pathways that impact metastasis.
     PLoS One. 2021;16:e0259128.
     PubMed     Abstract available
     
     
     
248. SUN Y, Ji Y
     AAWS-Net: Anatomy-aware weakly-supervised learning network for breast mass segmentation.
     PLoS One. 2021;16:e0256830.
     PubMed     Abstract available
     
     
     
249. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
     Clinical correlates of circulating cell-free DNA tumor fraction.
     PLoS One. 2021;16:e0256436.
     PubMed     Abstract available
     
     
     
250. HE X, Anthony DC, Catoni Z, Cao W, et al
     Pulmonary tumor embolism: A retrospective study over a 30-year period.
     PLoS One. 2021;16:e0255917.
     PubMed     Abstract available
     
     
     
251. LIN KH, Hsu HM, Hsu KF, Chu CH, et al
     Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study.
     PLoS One. 2021;16:e0261258.
     PubMed     Abstract available
     
     
     
252. HU Y, Zou D
     Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
     PLoS One. 2021;16:e0260811.
     PubMed     Abstract available
     
     
     
253. AWODUTIRE PO, Balogun OS, Olapade AK, Nduka EC, et al
     The modified beta transmuted family of distributions with applications using the exponential distribution.
     PLoS One. 2021;16:e0258512.
     PubMed     Abstract available
     
     
     
254. CHANG YY, Lin HJ, Hsiao LC, Lin YF, et al
     Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect.
     PLoS One. 2021;16:e0260533.
     PubMed     Abstract available
     
     
     
255. TANAKA M, Tanaka T, Takamatsu M, Shibue C, et al
     Effects of the Kampo medicine Yokukansan for perioperative anxiety and postoperative pain in women undergoing breast surgery: A randomized, controlled trial.
     PLoS One. 2021;16:e0260524.
     PubMed     Abstract available
     
     
     
256. KAUR P, Nagar S, Bhagwat M, Uddin M, et al
     Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
     PLoS One. 2021;16:e0260400.
     PubMed     Abstract available
     
     
     
257. ZHANG X, Kschischo M
     MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes.
     PLoS One. 2021;16:e0261183.
     PubMed     Abstract available
     
     
     
258. OZGENCIL M, Barwell J, Tischkowitz M, Izatt L, et al
     Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.
     PLoS One. 2021;16:e0260852.
     PubMed     Abstract available
     
     
     
259. HIRAMOTO S, Asano H, Miyamoto T, Takegami M, et al
     Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
     PLoS One. 2021;16:e0261473.
     PubMed     Abstract available
     
     
     
260. VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
     Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
     PLoS One. 2021;16:e0252311.
     PubMed     Abstract available
     
     
     
261. KIM HS, Kim MG, Min KW, Jung US, et al
     High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
     PLoS One. 2021;16:e0252052.
     PubMed     Abstract available
     
     
     
262. BADAWY SM, Mohamed AEA, Hefnawy AA, Zidan HE, et al
     Automatic semantic segmentation of breast tumors in ultrasound images based on combining fuzzy logic and deep learning-A feasibility study.
     PLoS One. 2021;16:e0251899.
     PubMed     Abstract available
     
     
     
263. HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
     Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
     PLoS One. 2021;16:e0251276.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: